Company intelligence / Profile preview

Fosun Pharma

Ownership: Public · 600196.SH, 02196.HK
Employees: ~40500
Development stage: Commercial

Overview

Fosun Pharma has a robust global pipeline of over eighty major innovative drugs/biosimilars spanning oncology, immunology/inflammation, CNS disorders, chronic diseases, vaccines/infectious disease. Notable commercialized products include Artesunate for severe malaria (>56 million patients treated worldwide), Han Li Kang rituximab biosimilar (>100k patients in China), Han Qu You trastuzumab biosimilar approved in China/EU. The company partners globally for mRNA COVID‑19 vaccines with BioNTech. Its R&D investment remains high (~RMB5.55 billion in FY2024). Clinical results show strong impact in both emerging markets and developed regions through innovation-driven launches.[6][7]

Therapeutic areas: Metabolic DisordersImmunologyOncologyNeurologyInfectious Diseases
Modalities: Small moleculesMonoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Cell therapiesVaccinesRadiopharmaceuticalsRNA therapeutics[4][7]
Industry: Biotech

Drug pipeline

17 assets

luvometinib

16 more assets in the full pipeline.

Request access →

Partnerships

BioNTech SE – strategic partnership for mRNA COVID‑19 vaccine distribution/development in ChinaSinopharm Group – strategic alliance/shareholding relationship expanding pharmaceutical commerce/distribution reach.[5]

Beyond the preview

Go deeper on Fosun Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fosun Pharma.

Explore the full profile